NCT06777927 Exergaming Training Among Hypertensive Patients
| NCT ID | NCT06777927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 81 participants |
| Start Date | 2025-01-16 |
| Primary Completion | 2025-10-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 81 participants in total. It began in 2025-01-16 with a primary completion date of 2025-10-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Since Hypertension affects all body systems and importantly postural balance control. So, the evidence indicates a strong link and connection between balance and hypertension through somatosensory, visual, vestibular, musculoskeletal, and CNS integration of inputs from both peripheral and motor systems. Therefore, to fill this gap of how much balance and each of its aspects/components are affected, this study will be done for a detailed examination of this genuine integration and clinical interaction among hypertensive with game-based techniques on all three balance components (concerning Intensity, frequency, duration and dosage of VRET). Secondly, on the other hand (CR) programs, have shown very low compliance with recommended Physical Activity, which is why; by utilising this alternative, Virtual reality exergaming can be used as a quick, appropriate and equivalent alternative to traditional exercise programs. Also, in future, it could be suggested with promising effects in the provision of engaging, goal-oriented training for patients with hypertensive besides a sound, economical and clinically beneficial alternative to traditional Cardiac Rehabilitation. Finally, by exploring detailed clinical integration of Postural Balance with Hypertension using Virtual Reality the study will be able to highlight hypertension as a potent risk factor for future impaired balance and risks of falls. Thereby, hypertension's early identification (considering all biological, psychological, and social factors) and prevention may avert hypertensive to future debilitating complications and outcomes as a result of it.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of Community dwelling controlled Hypertensive (particularly Stage 1, 130 to 139 (systolic) or 80 to 89 (diastolic) or Stage 2 hypertension from 140 or higher (systolic) or 90 (diastolic) if present with any (controlled diabetes or overweight patients) with a medical referral form for medical specialist with physiotherapeutic treatment provided by the local public or private healthcare system 2. Any race or gender with age 20 or older 3. No history of any orthopedic, neurological, Pulmonary or psychological disorders, Cognitive impairments etc. 4. Had not performed physical activity in the previous three months. Exclusion criteria: 1. Grade III or grade IV heart failure according to the New York Heart Association (NYHA) Functional Classification. 2. Recent acute myocardial infarction; unstable angina; acute pericarditis. pulmonary hypertension; uncontrolled diabetes mellitus; Hypertensive crises or uncontrolled Hypertension or Pregnancy 3. Patients who had three consecutive absences during the intervention 4. Unable to answer or understand the gaming or exercise protocols and quality of life questionnaires and fulfil the exercise protocols, due to any severe cognitive deficit 5. Pain with ambulation or dizziness when standing or walking. 6. Contraindications to treadmill walking or VR gaming
Contact & Investigator
Imran Amjad, PhD
PRINCIPAL INVESTIGATOR
Riphah International University Islamabad
Frequently Asked Questions
Who can join the NCT06777927 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 55 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777927 currently recruiting?
Yes, NCT06777927 is actively recruiting participants. Contact the research team at sana.bashir65@gmail.com for enrollment information.
Where is the NCT06777927 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT06777927 clinical trial?
NCT06777927 is sponsored by Riphah International University. The principal investigator is Imran Amjad, PhD at Riphah International University Islamabad. The trial plans to enroll 81 participants.